Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 25.

Law, Jennifer H., Habibi, Golareh, Hu, Kaiji, Masoudi, Hamid, Wang, Michelle. Y. C., Stratford, Anna L., Park, Eugene, Gee, Julia Margaret Wendy, Finlay, Pauline, Jones, Helen E., Nicholson, Robert Ian, Carboni, Joan, Gottardis, Marco, Pollak, Michael and Dunn, Sandra E. 2008. Phosphorylated insulin-like growth factor-I/insulin receptor is present in all breast cancer subtypes and is related to poor survival. Cancer Research 68 (24) , pp. 10238-10246. 10.1158/0008-5472.CAN-08-2755

Knowlden, Janice Mary, Jones, Helen E., Barrow, Denise, Gee, Julia Margaret Wendy, Nicholson, Robert Ian and Hutcheson, Iain Robert 2008. Insulin receptor substrate-1 involvement in epidermal growth factor receptor and insulin-like growth factor receptor signalling: implication for Gefitinib ('Iressa') response and resistance. Breast Cancer Research and Treatment 111 (1) , pp. 79-91. 10.1007/s10549-007-9763-9

Nicholson, Robert Ian, Hutcheson, Iain Robert, Jones, Helen Elizabeth, Taylor, Kathryn Mary, Hiscox, Stephen Edward and Gee, Julia Margaret Wendy 2008. Compensatory signalling induced by anti-hormone and anti-growth factor therapies in breast cancer: a starting point for the development of resistance to targeted therapies. In: Pasqualini, Jorge R. ed. Breast cancer: prognosis, treatment and prevention. 2nd ed, London: Informa Healthcare, pp. 123-136.

Hutcheson, Iain Robert, Knowlden, Janice Mary, Jones, Helen E., Burmi, R. S., McClelland, Richard Andrew, Barrow, Denise, Gee, Julia Margaret Wendy and Nicholson, Robert Ian 2006. Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapy. Endocrine-Related Cancer 13 (S1) , S89-S97. 10.1677/erc.1.01279

Jones, Helen E., Gee, Julia Margaret Wendy, Hutcheson, Iain Robert, Knowlden, Janice Mary, Barrow, Denise and Nicholson, Robert Ian 2006. Growth factor receptor interplay and resistance in cancer. Endocrine-Related Cancer 13 (S1) , S45-S51. 10.1677/erc.1.01275

Jones, Helen E., Gee, Julia Margaret Wendy, Hutcheson, Iain Robert and Nicholson, Robert Ian 2006. Growth factor pathway switching: implications for the use of gefitinib and trastuzumab. Breast Cancer Online 9 (7) , e27. 10.1017/S1470903106005451

Jones, Helen E., Gee, Julia Margaret Wendy, Barrow, Denise, Tonge, D., Holloway, B. and Nicholson, Robert Ian 2006. Inhibition of insulin receptor isoform-A signalling restores sensitivity to gefitinib in previously de novo resistant colon cancer cells. British Journal of Cancer 95 (2) , pp. 172-180. 10.1038/sj.bjc.6603237

Jones, Helen E., Gee, Julia Margaret Wendy, Barrow, Denise, Holloway, B., Tonge, D. and Nicholson, Robert Ian 2006. Maintenance of EGFR phosphorylation by the IGF-1R in the presence of gefitinib in lung cancer cells: Co-targeting the EGFR and IGF-1R maximises anti-tumour effects [Abstract]. Annals of Oncology 17 (S3) , iii39. 10.1093/annonc/mdl919

Gee, Julia Margaret Wendy, Howell, A., Gullick, W. J., Benz, C. C., Sutherland, R. L., Santen, R. J., Martin, L. A., Ciardiello, F., Miller, W. R., Dowsett, M., Barrett-Lee, Peter, Robertson, J. F. R., Johnston, S. R., Jones, Helen E., Wakeling, A. E., Duncan, R. and Nicholson, Robert Ian 2005. Consensus statement. Endocrine-Related Cancer 12 (S1) , S1-S7. 10.1677/erc.1.01054

Jones, Helen E., Gee, Julia Margaret Wendy, Taylor, Kathryn Mary, Barrow, Denise, Williams, Hywel David, Rubini, M. and Nicholson, Robert Ian 2005. Development of strategies for the use of anti-growth factor treatments. Endocrine-Related Cancer 12 (S1) , S173-S182. 10.1677/erc.1.01004

Nicholson, Robert Ian, Hutcheson, Iain Robert, Britton, David James, Knowlden, Janice Mary, Jones, Helen E., Harper, Maureen Elaine, Hiscox, Stephen Edward, Barrow, Denise and Gee, Julia Margaret Wendy 2005. Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. The Journal of Steroid Biochemistry and Molecular Biology 93 (2-5) , pp. 257-262. 10.1016/j.jsbmb.2004.12.006

Jones, Helen E., Goddard, Lindy, Gee, Julia Margaret Wendy, Hiscox, Stephen Edward, Rubini, M., Barrow, Denise, Knowlden, Janice Mary, Williams, Sophie E., Wakeling, A. E. and Nicholson, Robert Ian 2004. Insulin-like growth factor-1 receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells. Endocrine-Related Cancer 11 (4) , pp. 793-814. 10.1677/erc.1.00799

Hutcheson, Iain Robert, Gee, Julia Margaret Wendy, Barrow, Denise, Jones, Helen E., Wakeling, A. E. and Nicholson, Robert Ian 2004. Treatment of tamoxifen-resistant MCF-7 breast cancer cells with either gefitinib ('Iressa') or trastuzumab (Herceptin((R))) generates cross-resistant phenotypes [Abstract]. Breast Cancer Research and Treatment 88 (S1) , S145-S146. 10.1007/s10549-004-3602-z

Nicholson, Robert, Hutcheson, Iain Robert, Knowlden, Janice Mary, Jones, Helen E., Harper, Maureen Elaine, Jordan, Nicola Jane, Hiscox, Stephen Edward, Barrow, Denise and Gee, Julia Margaret Wendy 2004. Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clinical Cancer Research 10 (1) , 346s-354s. 10.1158/1078-0432.CCR-031206

Gee, Julia Margaret Wendy, Gutteridge, E., Robertson, J. F., Wakeling, A. E., Jones, Helen E. and Nicholson, Robert Ian 2004. Biological markers during early treatment of tamoxifen resistant breast cancer with gefitinib ('Iressa')[Abstract]. Breast Cancer Research and Treatment 88 (S1) , S32. 10.1007/s10549-004-3602-z

Jones, Helen E. 2003. Escherichia coli lacking the AcrAB multidrug efflux pump also lacks nonproteinaceous, PHB-polyphosphate Ca2+ channels in the membrane. Biochimica et Biophysica Acta (BBA) - Biomembranes 1612 (1) , pp. 90-97. 10.1016/S0005-2736(03)00082-8

Knowlden, Janice Mary, Hutcheson, Iain Robert, Jones, Helen E., Madden, Tracie-Ann, Gee, Julia Margaret Wendy, Harper, Maureen Elaine, Barrow, Denise, Wakeling, A. E. and Nicholson, Robert Ian 2003. Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology 144 (3) , pp. 1032-1044. 10.1210/en.2002-220620

Nicholson, Robert Ian, Jones, Helen E., Gee, Julia Margaret Wendy, Barrow, Denise, Hiscox, Stephen Eward, Harper, Maureen Elaine, Rubini, M., Guy, S. and Wakeling, A. E. 2003. Insulin-like growth factor-1 receptor signalling and acquired resistance to gefitinib ('Iressa', ZD1839) in MCF-7 human breast cancer cells [Abstract]. Breast Cancer Research and Treatment 82 (S1) , S171. 10.1023/A:1026252325164

Nicholson, Robert Ian, Hutcheson, Iain Robert, Harper, Maureen Elaine, Knowlden, Janice Mary, Barrow, Denise, McClelland, Richard Andrew, Jones, Helen E., Wakeling, A. E. and Gee, Julia Margaret Wendy 2002. Modulation of epidermal growth factor receptor in endocrine-resistant, estrogen-receptor-positive breast cancer. In: Castagnetta, L., Agostara, B., Massimo, L., Montalto, G. and Bradlow, H. L. eds. Hormone-Related Tumors: Novel Approaches to Prevention and Treatment, Annals of the New York Academy of Sciences, vol. 963. New York: The New York Academy of Sciences, pp. 104-115. (10.1111/j.1749-6632.2002.tb04101.x)

Nicholson, Robert Ian, Hutcheson, Iain Robert, Harper, Maureen Elaine, Knowlden, Janice Mary, Barrow, Denise, McClelland, Richard Andrew, Jones, Helen E., Wakeling, A. E. and Gee, Julia Margaret Wendy 2001. Modulation of epidermal growth factor receptor in endocrine-resistant, oestrogen receptor-positive breast cancer. Endocrine-Related Cancer 8 (3) , pp. 175-182. 10.1677/erc.0.0080175

Jones, Helen E., Barrow, Denise, Dutkowski, Carol, Goddard, Lindy, Smith, Christopher, Harper, Maureen E. and Nicholson, Robert Ian 2001. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: Identification of divergent growth regulatory pathways. The Prostate 49 (1) , pp. 38-47. 10.1002/pros.1116

Sala-Newby, G. B., Badminton, M. N., Evans, W. H., George, C. H., Jones, Helen E., Kendall, J. M., Ribeiro, A. R. and Campbell, Anthony Keith 2000. Targeted bioluminescent indicators in living cells. In: Ziegler, M., Baldwin, T., Abelson, J. and Simon, M. eds. Bioluminescence and Chemiluminescence Part C, Vol. 305. Methods in Enzymology, vol. 305. San Diego, CA: Academic Press, pp. 479-498.

Holland, I. B., Jones, Helen E., Campbell, Anthony Keith and Jacq, A. 1999. An assessment of the role of intracellular free Ca2+ in E-coli. Biochimie 81 (8-9) , pp. 901-907. 10.1016/S0300-9084(99)00205-9

Jones, Helen E., Holland, I. B., Baker, Helen Louise and Campbell, Anthony Keith 1999. Slow changes in cytosolic free Ca2+ in Escherichia coli highlight two putative influx mechanisms in response to changes in extracellular calcium. Cell Calcium 25 (3) , pp. 265-274. 10.1054/ceca.1999.0028

Jones, Helen E., Eaton, C. L., Barrow, Denise, Dutkowski, Carol Mary, Gee, Julia Margaret Wendy and Griffiths, K. 1997. Comparative studies of the mitogenic effects of epidermal growth factor and transforming growth factor-alpha and the expression of various growth factors in neoplastic and non-neoplastic prostatic cell lines. Prostate 30 (4) , pp. 219-231. 10.1002/(SICI)1097-0045(19970301)30:4<219::AID-PROS1>3.0.CO;2-G

This list was generated on Mon Dec 9 04:58:38 2019 GMT.